Study Objectives: To assess the presence of increased REM-related motor activity during sleep, by questionnaires for REM sleep behavior disorder (RBD), in participants with "isolated" REM sleep without atonia (RWA).
Introduction
In the earlier literature on REM sleep behavior disorder (RBD), participants who developed fully expressed RBD after longstanding subclinical behavioral events during sleep have been reported [1] . In 25% of these patients, the spouses reported that the behavior had been evident for decades, characterized by a chronic and often progressive (frequency and intensity) limb jerking and twitching, and talking/shouting during sleep (but without any reported associated dreaming) [1] ; according to the fact that it preceded RBD, it was termed "subclinical RBD." In the following years, the term "subclinical RBD" has been used to indicate the observation of dream enactment behaviors that, for different reasons, could not lead to a full set of signs and symptoms allowing the diagnosis of RBD in participants with "incidental" REM sleep without atonia (RWA) [2] [3] [4] [5] .
More recently, in parallel with the development of visual and automatic quantitative methods to evaluate RWA, another group of participants without RBD who do have "incidental" RWA, as defined by these quantitative methods, has been more and more frequently identified, even within the normal control groups [6] [7] [8] , especially in the older participants [9] .
It is not known whether these non-RBD participants with isolated and objectively assessed RWA have an increased risk of developing fully expressed RBD and/or neurodegenerative disease; however, it would be extremely important to obtain this type of information in well-planned and controlled longitudinal studies. Before this time-and resource-demanding type of study can be reasonably planned, it appears important to establish if non-RBD participants with isolated RWA (objectively and quantitatively assessed) also have an abnormal motor/behavioral pattern during sleep.
Therefore, the main objective of this study was to assess, by using validated screening questionnaires, the presence of a history of increased motor activity during sleep, in consecutive participants undergoing sleep video-polysomnography (vPSG) for any other reason and without a known diagnosis of RBD. The hypothesis was that individuals with isolated RWA might have an increased motor activity/behavioral pattern during sleep, although this activity does not allow us to diagnose RBD. Secondary aims were to quantify the prevalence of RWA in a large unselected population of patients accessing the sleep lab and to compare the clinical and PSG features of patients with and without RWA.
Participants and Methods

Participants
The participants to this study were consecutively enrolled, during 2015 and 2016, by the Department of Neurology IC, Sleep Research Centre, Oasi Institute, Troina, Italy and the Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Civic Hospital of Lugano, Lugano, Switzerland among all participants undergoing full-night laboratory sleep vPSG with the following inclusion criteria: age ≥18 years, sharing bedroom with a partner or roommate, absence of a severe health, neurological, or cognitive problem that would impair the comprehension of the study tasks, sleep recording without important artifact in the chin EMG signals, and presence of at least 5 min of REM sleep. Participants with a previous diagnosis of RBD were excluded.
All participants were carefully clinically assessed from both the general and hypnological points of view and a detailed clinical and pharmacological history was obtained, with particular attention to the ongoing drug therapy. Sleep disorders were diagnosed according to the ICSD-3 [10] , with the exception of restless legs syndrome (RLS) which was diagnosed following the International RLS Study Group Criteria [11] . The presence of cardiovascular, neurological (neurodegenerative diseases, in particular), cognitive, psychiatric, orthopedic, endocrine, otorhinolaryngoiatric, ocular, gastrointestinal, genitourinary, metabolic, hematologic, dermatologic, respiratory, and rheumatologic comorbidities was carefully assessed and noted. Regarding the ongoing drug therapy, the use of the following centrally acting substance classes was assessed, as well as the total number of drugs taken: hypnotics, antidepressants, dopamine agonists, antihypertensives, benzodiazepines, anticholinesterases, antipsychotics, sodium oxibate or modafinil, antiepileptics, and opiates.
The Mini-Mental State Evaluation was also collected from only a subgroup of patients enrolled in 2016, during the study period, because it was decided to make this amendment to the study protocol. All patients provided their informed consent and the study protocol was approved by the Oasi Research Institute Ethical Committee.
Assessment of the motor activity during sleep
To quantify the amount of motor activity during sleep, two questionnaires specifically built and validated for the screening of RBD were filled up by all participants, with the help, if required, by the bed partner or roommate.
The first, the RBD Screening Questionnaire (RBDSQ) [12] , is a 10-item, self-rating instrument investigating the participant's sleep behavior with short questions requiring only "yes" or "no" as a response. Even if for this questionnaire the bed partner or roommate input is not required, in our participants it was always available and encouraged. The first four items address the frequency and content of dreams and how they relate to nocturnal movements or behavior. The fifth item concerns selfinjuries and bed partner; item six includes four sub-items on nocturnal motor behavior (nocturnal vocalization, sudden limb movements, complex movements, or falling down from bed). The next two items assess nocturnal awakenings, item nine asks about disturbed sleep, and the last item 10 concerns the presence of any neurological disorder. The maximum total score of the RBDSQ is 13 points and it has been reported that ≥5 points can be considered to be a positive test result for RBD, with high sensitivity (0.96) but lower specificity (0.56) [12] . However, it was also reported that this test performed poorly for the discrimination of patients with possible confounding conditions, such as sleepwalking or epilepsy [12] . The cutoff value for this test when applied to discriminate between patients with Parkinson's disease with or without RBD was reported to be slightly higher (≥6 points) [13] .
The RBD questionnaire-Hong Kong (RBDQ-HK) is a selfadministered questionnaire that can be filled in also by or in collaboration with the bed partner. It comprises 13 questions assessing different clinical features of RBD [14] . Each item is assessed for lifetime occurrence and frequency during the last year. For questions 1 to 5 and 13, lifetime items allow three response options: "don't know" = 0, "no" = 0, or "yes" = 1 while last-year frequency items require a scoring on a five-point scale (i.e. none = 0, yes/once or few times/year = 1, once or few times/ month = 2, one-two times/week = 3, and three times or more/ week = 4). For questions 6 to 12, lifetime items also allow three response options: "don't know" = 0, "no" = 0, or "yes" = 2 while last-year frequency items require a scoring on a five-point scale (i.e. none = 0, yes/once or few times/year = 2, once or few times/ month = 4, one or two times/week = 6, three times or more/ week = 8).
The total RBDQ-HK score is calculated by summing up the scores of all lifetime items and last-year frequency items, giving a range from 0 to 100 and the best cutoff was found to be 18/19 [14] . With this cutoff, the authors reported moderate-tohigh sensitivity (0.82), specificity (0.87), positive predictive value (0.86), and negative predictive value (0.83), accompanied by high internal consistency and test-retest reliability.
Polysomnographic sleep recording
A vPSG full-night recording was obtained for each patient. The recording included electroencephalogram (EEG, with at least three channels: one frontal, one central, and one occipital, referred to the contralateral earlobe); electrooculogram (two channels); electromyogram (EMG) of the submentalis muscle and of both tibialis anterior muscles; and electrocardiogram (one derivation). All recordings lasted at least for 6 hr. The sleep respiratory pattern of each patient recruited by the Troina center was polygraphically assessed in a previous recording (within 1 week) or during the same recording while all recordings made in Lugano included respiratory channels.
Sleep stages were visually scored on 30 s epochs [15] and epochs containing technical artifacts or extremely elevated muscle activity causing saturation of amplifiers were carefully detected and marked for exclusion from the subsequent quantitative EMG analysis.
Quantification of the submentalis muscle EMG amplitude
For the computer quantitative analysis of the submentalis muscle EMG activity, we used an established automatic scoring algorithm [6, 7, 16] . The submentalis muscle EMG signal was digitally bandpass filtered at 10-100 Hz, with a notch filter at 50 Hz and rectified. Subsequently, each REM sleep epoch included in the analysis was divided into thirty 1 s mini-epochs. The average amplitude of the rectified submentalis muscle EMG signal was then obtained for each mini-epoch. After a noise reduction procedure [7] , the values of the submentalis muscle EMG signal amplitude in each 1 s mini-epoch were used to compute the percentage of values in the following 20 amplitude (amp) classes (expressed in µV): amp ≤ 1, 1 < amp ≤ 2, …, 18 < amp ≤ 19, amp > 19. Muscle atonia is expected to be reflected by high values of the first class (amp ≤ 1) while phasic and tonic activations are expected to increase the value of the other classes [6, 7, 16] . As proposed in previous studies, an index summarizing in a single value the degree of preponderance of the first class was used in REM sleep:
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Mathematically, this index can vary from 0 (absence of miniepochs with amp ≤ 1), i.e. complete absence of EMG atonia, to 1 (all mini-epochs with amp ≤ 1) or stable EMG atonia . The Atonia Index correlates significantly with the percentage of epochs of RWA detected by the method by Lapierre and Montplaisir [6, [17] [18] [19] .
We have already suggested in previous publications, based on careful statistical evaluations, to use a three-level classification of Atonia Index: >0.9 normal; 0.8-0.9 mildly abnormal, and <0.8 definitely abnormal [7, 18, 19] . Thus, in this study, the <0.8 threshold was used in order to select cases with a definitely abnormal Atonia Index. The algorithm was run blind to the condition of the participant, even though no manual modifications of the parameters are possible.
Statistical analysis
For the statistical analysis, all comparisons were performed by means of the Student's t-test for unpaired datasets or the factorial ANOVA when more than one grouping variable was needed. The differences in the frequency of sleep disorders, comorbidities, and drug treatment were analyzed by means of the chi-square test. Finally, a generalized (multiple) regression model analysis was performed to evaluate the correlation between the value of Atonia Index (dependent variable) and different parameters identified in the study. The commercially available Statistica software package (StatSoft, Inc., 2001. STATISTICA data analysis software system, version 6. www. statsoft.com) was used. Differences were considered significant when they were below the p < 0.05 level.
Results
In total, 249 participants were recruited in 13 of whom a new diagnosis of RBD was posed (9 males and 4 females, mean age 64.7 years, 13.34 SD) [10] ; the remaining 236 participants without RBD (120 males and 116 females) were significantly younger (mean age 54.8 years, 16.51 SD, p < 0.04) ( Table 1) . As expected, the mean RBDSQ and RBDQ-HK scores were significantly higher and Atonia Index significantly lower in the RBD patients than in non-RBD participants. None of the PSG parameters considered resulted to be significantly different in these two groups.
Subsequently, the non-RBD participants were subdivided into two subgroups, based on the Atonia Index computed in their PSG, one with "low" Atonia Index (<0.8) and the other with "high" Atonia Index (≥0.8). Low Atonia Index was found in 34 participants (24 males and 9 females, mean age 59.8 years, 16.54 SD), whereas 202 participants exhibited a high Atonia Index (95 males and 107 females, mean age 54.0 years, 16.40 SD). The sex distribution in these two groups was significantly different (chi-square 8.18, p < 0.0045) with a preponderance of males within the subgroup with low Atonia Index while age was not significantly different (Table 2 ). These participants with low Atonia Index differed from the others also for several other parameters (table 2) among those considered in this study: MMSE was lower; RBDSQ and RBDQ-HK were both higher, and number of drugs taken and number of comorbidities. Some PSG parameters also differed between these two groups, including number of stage shifts and of awakenings, wakefulness after sleep onset, and sleep stage N1 which were all increased in the subgroup with low Atonia Index, whereas sleep efficiency, and sleep stages N2 and N3 were decreased. Periodic leg movements during sleep (PLMS) Index tended to be higher in participants with low Atonia Index but the difference did not reach statistical significance.
The comparison between the frequency of sleep disorders, comorbidities, and the different drug treatment in the two non-RBD subgroups of participants is reported in Table 3 . Almost all comparisons were not statistically significant, with the exception of cognitive comorbidities (in general, a mild memory impairment) and otorhinolaryngoiatric or ocular pathology, which seemed to be more frequent in the low Atonia Index subgroup; however, if these results are corrected for the multiple testing carried out, they also do not appear to be significant. In particular, we did not find a different frequency of antidepressant use between these two subgroups; this was accompanied by a lack of difference in Atonia Index between participants taking or not antidepressants in each subgroup, as detailed in Figure 1 . Additionally, 
Discussion
The results obtained in this study seem to fully confirm our original hypothesis that individuals with isolated RWA have an increased motor activity/behavioral pattern during sleep, although this activity does not allow us to diagnose RBD because no vocalization or complex behaviors were reported by roommates nor were observed during the sleep studies. As clearly shown in the tables and better evident in Supplementary Figure, all the mean values of the behavioral scales RBDSQ and RBDQ-HK (total and subscales "frequency" and "presence") obtained in the low Atonia Index participants are intermediate between those of the RBD patients and those of the high Atonia Index participants. This further clarifies why RBD was not diagnosed in these patients and is in agreement with the observation of dream enactment behaviors that, for different reasons, are not enough to make the diagnosis of RBD in participants with "incidental" RWA [2] [3] [4] [5] .
With this study, we cannot establish if the condition that we have identified can predate a fully blown RBD, as reported by Schenck et al. [1] in some RBD patients in whom the spouses reported that limb jerking and twitching, and talking/shouting during sleep, without any reported associated dreaming had been present even for decades. However, given that we have identified a group of participants without RBD but with REM sleep-related chin EMG and behavioral changes similar to that of RBD patient, but with a lower intensity, we believe that this condition might be called "subclinical RBD." However, an alternative interpretation can be proposed and the condition can be considered to be a "mild" RBD. In both cases, at this stage, it cannot be considered to be an indication of probable conversion to a more severe and clinical RBD but strongly suggests the need of well-planned prospective longitudinal studies that are now warranted.
It is interesting to note that despite the fact that participants with low Atonia Index had a clearly more disturbed sleep structure than those with high Atonia Index, as well as a higher number of comorbidities and used a higher number of drugs, indicating a possibly more severe general clinical picture, none of these parameters nor the coexistence of each different sleep pathology resulted to influence RWA which was only and highly correlated with the behavior changes picked up by the RBDQ-HK. This might indicate that our results, even if obtained in a sample of patients with sleep disorders, might apply to some extent to the general population. We cannot certainly conclude in this sense but our data further indicate the need to extend this type of study to the general population.
It is also possible that our participants with low Atonia Index and increased motor/behavior activity overlap, to some extent, with the participants reported to present, during sleep, the socalled REM sleep behavioral events [20] . These events were found in many non-RBD patients with Parkinson's disease but also in a sizeable proportion, approximately 13.9%, of the healthy control group [20] , a figure strikingly similar to our finding of 14.4% (34 out of 236) of non-RBD participants with low Atonia Index. We cannot exclude that our patients might have at home REM sleep behavioral events that we have not seen during the sleep studies. Moreover, this indirectly supports the speculation that our results might also apply to the general population.
It is important to consider the value that the identification of this condition might assume, if it is demonstrated, in the future, that it might represent a risk factor for the development of RBD. RBD itself represents a risk factor or a prodromal stage for the development of a series of neurodegenerative conditions, especially within the group of synucleinopathies [21] [22] [23] . However, RBD can predate the development of neurodegeneration even by decades [23] , allowing a theoretical long time window for an eventual neuroprotective intervention (not yet available). Identifying a condition that might evolve to RBD and, then, to neurodegeneration is an important achievement that might provide more time to an effective but slowly acting neuroprotective intervention. As already mentioned, no effective neuroprotective intervention is now available but research is active in this field and the scientific world has already produced guidelines for a correct development of this type of treatment [24] . Thus, the obvious consequence of the data reported in this paper is the need to assess the rate of isolated RWA with increased motor/behavioral activity in the general population and the predictive factors of its eventual progression to fully expressed RBD.
Finally, our findings seem to indicate the need to enlarge the clinical spectrum of RBD that, if confirmed, would increase the epidemiological importance of this condition.
